Need to do a safety trial for CP2. They would have to be 100%...

Need to do a safety trial for CP2.
They would have to be 100% certain of CP2 to use it in a trial.
Still seems to be a while off.
Canada would seem the place for CP2 trial but Cecere doesn't do minimally invasive.
I can see they want CP2 to be a demonstratably better product than CP1 above and beyond not having drive lines.
Possible problems, Clinical, Technical, competing technology, staff not good enough to get C-Pulse to an inflection point.
Last one looks most likely. Doctors risking their reputation and working on a complex new product would only like to deal with the best.
SSH personnel have been moving up a notch so company claim is plausible.
Slow cautious progress to inflection point as usual absolute effort seems to be on making the base stronger with success.